The subsidy landscape is responding quickly to the COVID-19 virus and the problems this crisis causes world-wide. A lot of new funding opportunities are being released to assist researchers and companies with their Research and Development activities against COVID-19. This overview of all available calls will be updated regularly. Catalyze can help you to find what you need in this rapidly changing subsidy landscape and is available to assist you in writing successful proposals.
CEPI: Achieving an unprecedented acceleration of vaccine development and global manufacturing capacity to prevent COVID-19
Subsidy: not specified.
Deadline: open on rolling basis (at least untill 30 June 2020, applications will be reviewed every 2 weeks)
Consortium: open worldwide, to all types of organization: for-profit companies; non-profit organisations; international institutions and foundations; joint R&D ventures; government research organisations; and other vaccine developers. In the consortium a manufactures should be included, and a member with experience in human vaccine development.
Scope: The objective of this Call for Proposals is to support the rapid development of vaccines with a goal of achieving licensure/emergency authorization in 12-18 months or less and to ensure the availability of sufficient doses for wide-spread global deployment as soon as possible in 2021.
This Call will be of potential interest to organizations who have already secured resources for a vaccine candidate for a given COVID-19 target indication or region, and now seek additional support, based on the above principles, to aid expansion of global development plans, support large clinical trials, and/or widen the geographical manufacturing footprint.
NIH: NIAID – Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01, Clinical Trial Not Allowed) – PAR-20-178
Subsidy: no limit
Deadline: Applications will be accepted on a rolling basis, beginning on 30 April 2020.
Consortium: Both US and non-US for profit and non-profit organizations can apply.
Scope: The purpose of this grant is to provide an expedited funding mechanism for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). Examples of research areas are: studies to understand the viral infection, replication and pathogenesis, studies to understand viral transmission, identification and characterization of immunity, development of clinical diagnostic tests and therapeutics (in vitro, ex vivo or animal models), vaccines, and more.
For more information: https://www.catalyze-group.com/covid-19-grants-and-funding/